Balyasny Asset Management L.P. bought a new position in eHealth, Inc. (NASDAQ:EHTH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 17,125 shares of the financial services provider’s stock, valued at approximately $161,000. Balyasny Asset Management L.P. owned about 0.06% of eHealth as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. R Squared Ltd bought a new stake in shares of eHealth during the fourth quarter valued at approximately $29,000. Prudential Financial Inc. bought a new stake in shares of eHealth in the 4th quarter worth $111,000. XTX Topco Ltd purchased a new position in shares of eHealth in the fourth quarter worth $145,000. Barclays PLC raised its stake in shares of eHealth by 104.3% in the third quarter. Barclays PLC now owns 47,445 shares of the financial services provider’s stock worth $194,000 after purchasing an additional 24,224 shares during the last quarter. Finally, Paloma Partners Management Co bought a new position in shares of eHealth during the fourth quarter valued at $210,000. Institutional investors own 79.54% of the company’s stock.
eHealth Price Performance
eHealth stock opened at $4.42 on Monday. eHealth, Inc. has a one year low of $3.58 and a one year high of $11.36. The stock has a fifty day moving average of $6.16 and a 200 day moving average of $7.37. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.10 and a current ratio of 3.10. The stock has a market cap of $134.05 million, a PE ratio of -1.55 and a beta of 1.11.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on EHTH shares. UBS Group decreased their target price on eHealth from $9.50 to $7.00 and set a “neutral” rating for the company in a research report on Thursday, May 8th. StockNews.com lowered shares of eHealth from a “buy” rating to a “hold” rating in a research note on Sunday, May 11th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, eHealth presently has a consensus rating of “Hold” and a consensus price target of $6.75.
Read Our Latest Stock Analysis on eHealth
About eHealth
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
See Also
- Five stocks we like better than eHealth
- Want to Profit on the Downtrend? Downtrends, Explained.
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Options Trading – Understanding Strike Price
- Savvy Investors Are Raising a Glass for Heineken Stock
- 5 Top Rated Dividend Stocks to Consider
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for eHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eHealth and related companies with MarketBeat.com's FREE daily email newsletter.